Search research articles
Contact Us
Filters
Showing results (121-130 of 224) with videos related to
Page
of 23
Sort By:
Oncology Reviews
|
August 13, 2020
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
Giuseppe Luigi Banna, Ornella Cantale, Melissa Bersanelli, et al.
Tumori
|
April 25, 2015
Inferior mesenteric artery chemoembolization and chemotherapy for advanced rectal cancer: report of a clinical case
Roberto Bini, Simone Comelli, Alfredo Addeo, et al.
Clinical Genitourinary Cancer
|
April 14, 2021
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy
Francesco Rundo, Melissa Bersanelli, Valeria Urzia, et al.
Gynecologic Oncology Reports
|
July 3, 2020
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with <i>CSMD3</i> mutation
Julie Terzic, Amanda Seipel, Jean Dubuisson, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, et al.
Anticancer Research
|
August 17, 2005
Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy
Graziella Bellone, Anna Novarino, Isabella Chiappino, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2005
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
Vincenzo Dongiovanni, Lucio Buffoni, Alfredo Berruti, et al.
Current Oncology Reports
|
November 4, 2021
A New Generation of Vaccines in the Age of Immunotherapy
Alfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.
Frontiers in Oncology
|
July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer
Emilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Anticancer Research
|
June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
Giuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 224) with videos related to
Sort By:
Page
of 23
Oncology Reviews
|
August 13, 2020
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
Giuseppe Luigi Banna, Ornella Cantale, Melissa Bersanelli, et al.
Tumori
|
April 25, 2015
Inferior mesenteric artery chemoembolization and chemotherapy for advanced rectal cancer: report of a clinical case
Roberto Bini, Simone Comelli, Alfredo Addeo, et al.
Clinical Genitourinary Cancer
|
April 14, 2021
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy
Francesco Rundo, Melissa Bersanelli, Valeria Urzia, et al.
Gynecologic Oncology Reports
|
July 3, 2020
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with <i>CSMD3</i> mutation
Julie Terzic, Amanda Seipel, Jean Dubuisson, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, et al.
Anticancer Research
|
August 17, 2005
Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy
Graziella Bellone, Anna Novarino, Isabella Chiappino, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2005
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
Vincenzo Dongiovanni, Lucio Buffoni, Alfredo Berruti, et al.
Current Oncology Reports
|
November 4, 2021
A New Generation of Vaccines in the Age of Immunotherapy
Alfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.
Frontiers in Oncology
|
July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer
Emilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Anticancer Research
|
June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
Giuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.
Page
of 23